Simulations Plus teams with ETC to advance IVIVC in drug delivery
Simulations Plus (SLP) announced that it has entered a new funded collaboration with the Enabling Technologies Consortium ETC . This ...
News Medical on MSN5d
New compound Z526 combats cancer-associated cachexia in preclinical models
In a recent study, researchers demonstrated that Z526, a novel dithiocarbamate-like compound, mitigates cancer-associated cachexia (CAC) both in vitro and in vivo.
BioWorld1mon
OPN-6602 exhibits potency against multiple myeloma in vitro and in vivo
Opna Bio AG has presented promising data regarding their EP300/CBP inhibitor OPN-6602 for the treatment of multiple myeloma (MM). The inhibition of EP300/CBP causes cell cycle arrest and apoptosis in ...
GEN6d
Addition to T Cell Expansion Media Leads to Improved Antitumor Efficacy in Mice
Researchers identify glucose usage as one major divergence betweenT cells expanding in vitro versus those expanding in vivo.